Two-year trajectories of COVID-19 symptoms and their association with illness perception: A prospective cohort study in Amsterdam, the Netherlands

Elke Wynberg, Anouk Verveen, Hugo D. G. van Willigen, Pythia Nieuwkerk, Udi Davidovich, Anja Lok, Menno D. de Jong, Godelieve J. de Bree, Tjalling Leenstra, Hans Knoop, Maria Prins, Anders Boyd, Ivette Agard, Jane Ayal, Floor Cavdar, Marianne Craanen, Annemarieke Deuring, Annelies van Dijk, Maartje Dijkstra, Ertan ErsanLaura del Grande, Joost Hartman, Nelleke Koedoot, Romy Lebbink, Dominique Loomans, Agata Makowska, Tom du Maine, Ilja de Man, Amy Matser, Lizenka van der Meij, Marleen van Polanen, Maria Oud, Clark Reid, Leeann Storey, Marc van Wijk, Joost van den Aardweg, Joyce van Assem, Marijne van Beek, Orlane Figaroa, Leah Frenkel, Marit van Gils, Xiaochuan Han, Agnes Harskamp-Holwerda, Mette Hazenberg, Soemeja Hidad, Nina de Jong, Neeltje Kootstra, Lara Kuijt, Eric P. Moll van Charante, Colin Russell, Karlijn van der Straten, Annelou van der Veen, Bas Verkaik, Gerben-Rienk Visser, RECoVERED Study Group

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Background: We used data from a prospective cohort to explore 2-year trajectories of ‘long COVID’ (persistent symptoms after SARS-CoV-2 infection) and their association with illness perception. Methods: RECoVERED participants (adults; prospectively enrolled following laboratory-confirmed SARS-CoV-2 infection, May 2020–June 2021) completed symptom questionnaires at months 2–12, 18 and 24, and the Brief Illness Perception Questionnaire (B-IPQ) at months 1, 6 and 12. Using group-based trajectory models (GBTM), we modelled symptoms (mean total numbers and proportion with four specific complaints), including age, sex, BMI and timing of infection as covariates. In a multivariable linear mixed-effects model, we assessed the association between symptom trajectories and repeated B-IPQ scores. Results: Among 292 participants (42% female; median age 51 [IQR = 36–62]), four trajectories were identified, ranging from Trajectory 4 (8.9%; 6 + symptoms) to Trajectory 1 (24.8%; no symptoms). The occurrence of fatigue and myalgia increased among 23% and 12% of participants, respectively. Individuals in Trajectory 4 experienced more negative adjusted B-IPQ scores over time than those in Trajectories 1–3. Conclusions: We observed little fluctuation in the total number of symptoms, but individual symptoms may develop as others resolve. Reporting a greater number of symptoms was congruent with more negative illness perception over time.
Original languageEnglish
Article numbere13190
Pages (from-to)e13190
JournalInfluenza and other respiratory viruses
Volume17
Issue number10
DOIs
Publication statusPublished - 1 Oct 2023

Keywords

  • Adult
  • COVID-19
  • COVID-19/epidemiology
  • Female
  • Humans
  • Male
  • Middle Aged
  • Netherlands/epidemiology
  • Perception
  • Prospective Studies
  • SARS-CoV-2
  • Surveys and Questionnaires
  • illness perception
  • sequelae
  • symptoms
  • trajectories

Cite this